BioPoly was issued U.S. Patent No. 12,208,013 in protection of the BioPoly Hill-Sachs Implant, designed to stabilize the shoulder joint in patients experiencing chronic dislocations while preserving the integrity of opposing cartilage.
With a robust intellectual property portfolio of more than two dozen patents, BioPoly safeguards its proprietary designs, manufacturing methods and materials. The company’s patented BioPoly synthetic cartilage material—a combination of ultrahigh molecular weight polyethylene and hyaluronic acid—is engineered to mimic the function of natural cartilage during joint restoration.
BioPoly was issued U.S. Patent No. 12,208,013 in protection of the BioPoly Hill-Sachs Implant, designed to stabilize the shoulder joint in patients experiencing chronic dislocations while preserving the integrity of opposing cartilage.
With a robust intellectual property portfolio of more than two dozen patents, BioPoly safeguards its...
BioPoly was issued U.S. Patent No. 12,208,013 in protection of the BioPoly Hill-Sachs Implant, designed to stabilize the shoulder joint in patients experiencing chronic dislocations while preserving the integrity of opposing cartilage.
With a robust intellectual property portfolio of more than two dozen patents, BioPoly safeguards its proprietary designs, manufacturing methods and materials. The company’s patented BioPoly synthetic cartilage material—a combination of ultrahigh molecular weight polyethylene and hyaluronic acid—is engineered to mimic the function of natural cartilage during joint restoration.
Copy to clipboard 
